Santen Inc.

GPTKB entity

Properties (68)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Ophthalmic_division_of_Merck_&_Co.
Santen USA, Inc.
gptkbp:advertising gptkb:Mr._Akira_Matsumoto
gptkbp:awards Various industry awards
gptkbp:budget Available online
gptkbp:CEO Akihiro_Santen
gptkbp:clinicalTrials Ongoing
Yes
Phase 1
Phase 2
Phase 3
gptkbp:collaborations Academic institutions
gptkbp:communityEngagement Yes
gptkbp:employees Approximately 2,000
gptkbp:establishedIn gptkb:Japan
gptkbp:focusArea Eye diseases
gptkbp:founded 1890
gptkbp:globalPresence Yes
gptkbp:headCoach gptkb:Mr._Taro_Suzuki
gptkb:Mr._Shunji_Takeda
gptkb:Ms._Haruka_Nishida
gptkb:Ms._Rika_Fujimoto
gptkb:Mr._Hiroki_Takeda
gptkb:Ms._Emi_Kobayashi
gptkb:Mr._Hiroshi_Watanabe
gptkb:Mr._Kenji_Yamamoto
gptkb:Mr._Junpei_Sakamoto
gptkb:Mr._Masashi_Ito
gptkb:Ms._Aiko_Nakamura
gptkb:Mr._Shohei_Tanaka
gptkb:Mr._Kazuhiro_Matsuda
gptkb:Mr._Yoshio_Nakagawa
gptkb:Ms._Yumi_Saito
Dr. Hiroshi Takahashi
Dr. Akiko Sato
Mr. Ryoichi Sato
gptkbp:headOfMarketing gptkb:Ms._Sayaka_Taniguchi
gptkb:Mr._Tetsuya_Yamashita
gptkb:Ms._Yuki_Tanaka
Dr. Masato Yoshida
gptkbp:headquarters gptkb:Osaka,_Japan
https://www.w3.org/2000/01/rdf-schema#label Santen Inc.
gptkbp:industry Pharmaceuticals
gptkbp:insuranceAccepted gptkb:Ms._Keiko_Yamada
gptkbp:investmentFocus Yes
R&D in ophthalmology
gptkbp:market Approximately $5 billion
Global
gptkbp:partnerships Various global pharmaceutical companies
gptkbp:patentCitation Numerous in ophthalmology
gptkbp:philanthropy Eye health initiatives
gptkbp:productLine Prescription medications
Over-the-counter products
gptkbp:products Eye drops
gptkbp:research_areas Cataracts
Glaucoma
Retinal diseases
Allergic conjunctivitis
Dry eye syndrome
gptkbp:researchAndDevelopment Yes
gptkbp:revenue $1 billion
gptkbp:specializesIn Ophthalmology
gptkbp:stockSymbol TSE: 4536
gptkbp:subsidiary gptkb:Santen_Pharmaceutical_Co.,_Ltd.
gptkbp:sustainabilityInitiatives Yes
gptkbp:trademark Santen
gptkbp:website www.santen.com